FIRST-LINE DASATINIB PLUS CONVENTIONAL CHEMOTHERAPY IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE KOREAN PROSPECTIVE PHASE II STUDY

被引：0

作者：

Lee, S. ^{[1
]}

Kim, D. W. ^{[1
]}

Kim, Y. J. ^{[1
]}

Yhim, H. Y. ^{[2
]}

Kwak, J. Y. ^{[2
]}

Yang, D. H. ^{[3
]}

Lee, J. J. ^{[3
]}

Kim, S. J. ^{[4
]}

Kim, J. S. ^{[4
]}

Park, S. J. ^{[5
]}

Choi, C. W. ^{[5
]}

Eom, H. S. ^{[6
]}

Park, S. K. ^{[7
]}

Lee, J. W. ^{[1
]}

Min, W. S. ^{[1
]}

Park, C. W. ^{[1
]}

机构：

[1] Catholic Univ Korea, Catholic BMT Ctr, Seoul, South Korea

[2] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea

[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun Gun, Jeollanamdo, South Korea

[4] Yonsei Univ, Coll Med, Seoul, South Korea

[5] Korea Univ, Coll Med, Seoul, South Korea

[6] Natl Canc Ctr, Ilsan, South Korea

[7] Soonchunhyang Univ, Sch Med, Bucheon, South Korea

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1123

引用

页码：462 / 463

页数：2

共 50 条

[41] Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study
Baek, Dong Won
Park, Han-Seung
Sohn, Sang Kyun
Kim, Dae Young
Kim, Inho
Ahn, Jae-Sook
Do, Young Rok
Lee, Se Ryeon
Eom, Hyeon-Seok
Lee, Won-Sik
Kim, Sung-Hyun
Lee, Ho Sup
Lee, Yoo Jin
Moon, Joon Ho
Lee, Je-Hwan
KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 734 - +
[42] Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Sugiura, Isamu
Doki, Noriko
Hata, Tomoko
Cho, Ryuko
Ito, Toshiro
Suehiro, Youko
Tanaka, Masatsugu
Kako, Shinichi
Matsuda, Mitsuhiro
Yokoyama, Hisayuki
Ishikawa, Yuichi
Taniguchi, Yasuhiro
Hagihara, Maki
Ozawa, Yukiyasu
Ueda, Yasunori
Hirano, Daiki
Sakura, Toru
Tsuji, Masaaki
Kamae, Tsuyoshi
Fujita, Hiroyuki
Hiramoto, Nobuhiro
Onoda, Masahiro
Fujisawa, Shin
Hatta, Yoshihiro
Dobashi, Nobuaki
Nishiwaki, Satoshi
Atsuta, Yoshiko
Kobayashi, Yukio
Hayakawa, Fumihiko
Ohtake, Shigeki
Naoe, Tomoki
Miyazaki, Yasushi
BLOOD ADVANCES, 2022, 6 (02) : 624 - 636
[43] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Ottmann, O. G.
Larson, R. A.
Kantarjian, H. M.
le Coutre, P. D.
Baccarani, M.
Hochhaus, A.
Kim, D. W.
Fan, X.
Novick, S.
Giles, F. J.
LEUKEMIA, 2013, 27 (06) : 1411 - 1413
[44] Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study
Jabbour, Elias
Martinelli, Giovanni
Vignetti, Marco
Kantarjian, Hagop
Gomez-Almaguer, David
Minami, Yosuke
Dombret, Herve
Hennessy, Meliessa
Vorog, Alexander
Wang, Bingxia
Ribera, Josep-Maria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S269 - S269
[45] Combination of Olverembatinib and VP Regimen As First-Line Therapy for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Xu, Gaixiang
Lou, Yinjun
Wang, Huafeng
Yu, Wen-Juan
Mao, Liping
Huang, Jian
Li, Chenying
Suo, Shanshan
Tong, Hongyan
Jin, Jie
BLOOD, 2023, 142
[46] Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy
Ohno R.
Current Hematologic Malignancy Reports, 2006, 1 (3) : 180 - 187
[47] UPDATED RESULTS OF A PHASE II STUDY OF HYPER-CVAD PLUS PONATINIB AS FRONTLINE THERAPY FOR ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Short, N.
Kantarjian, H.
Ravandi, F.
Daver, N.
Pemmaraju, N.
Thomas, D.
Yilmaz, M.
Kadia, T.
Sasaki, K.
Garris, R.
Garcia-Manero, G.
DiNardo, C.
Konopleva, M.
Estrov, Z.
Jain, N.
Wierda, W.
Jeanis, V.
Cortes, J.
O'Brien, S.
Jabbour, E.
HAEMATOLOGICA, 2017, 102 : 198 - 198
[48] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
Hisashi Sakamaki
Ken-ichi Ishizawa
Masafumi Taniwaki
Shin Fujisawa
Yasuo Morishima
Kensei Tobinai
Masaya Okada
Kiyoshi Ando
Noriko Usui
Shuichi Miyawaki
Atae Utsunomiya
Nobuhiko Uoshima
Tadashi Nagai
Tomoki Naoe
Toshiko Motoji
Itsuro Jinnai
Mitsune Tanimoto
Yasushi Miyazaki
Kazunori Ohnishi
Shinsuke Iida
Shinichiro Okamoto
Taku Seriu
Ryuzo Ohno
International Journal of Hematology, 2009, 89 : 332 - 341
[49] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
Sakamaki, Hisashi
Ishizawa, Ken-ichi
Taniwaki, Masafumi
Fujisawa, Shin
Morishima, Yasuo
Tobinai, Kensei
Okada, Masaya
Ando, Kiyoshi
Usui, Noriko
Miyawaki, Shuichi
Utsunomiya, Atae
Uoshima, Nobuhiko
Nagai, Tadashi
Naoe, Tomoki
Motoji, Toshiko
Jinnai, Itsuro
Tanimoto, Mitsune
Miyazaki, Yasushi
Ohnishi, Kazunori
Iida, Shinsuke
Okamoto, Shinichiro
Seriu, Taku
Ohno, Ryuzo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 332 - 341
[50] Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Lim, Sung-Nam
Lee, Kyoo-Hyung
Kim, Dae-Young
Lee, Je-Hwan
Lee, Jung-Hee
Chi, Hyun-Sook
Joo, Young-Don
Lee, Won Sik
Lee, Sang Min
Park, Seonyang
Kim, Inho
Sohn, Sang Kyun
Moon, Joon Ho
Ryoo, Hun-Mo
Bae, Sung Hwa
Kim, Min Kyoung
Yang, Deok-Hwan
Eom, Hyeon-Seok
Lee, Gyeong-Won
Jung, Chul Won
Won, Jong-Ho
Kim, Hawk
Lee, Jae-Hoon
Shin, Ho-Jin
Kim, Ho Young
Hyun, Myung Soo
Kim, Hyeoung Joon
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →